Skip to search formSkip to main contentSkip to account menu

Wnt Signaling Inhibitor SM04755

Known as: SM04755 
An orally bioavailable small molecule inhibitor of the Wnt signaling pathway, with potential antineoplastic activity. Upon oral administration, Wnt… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
THU0046 Small molecule inhibitor of the wnt pathway (SM04755) as a potential topical treatment for psoriasis
Background Psoriasis (PSO) is an autoimmune disease, causing patches of thick, inflamed, scaly skin due to excessive… 
2018
2018
THU0522 Experimental tendinopathy treatment with sm04755, a topical small molecule inhibitor of the wnt pathway
Background Tendinopathy is an inflammatory and degenerative disorder caused by injuries and overuse. Affected tendons become… 
2017
2017
SAT0607 Discovery of a small molecule inhibitor of the WNT pathway (SM04755) as a potential topical treatment for tendinopathy
Background Tendinopathy is an inflammatory and degenerative disorder caused by injuries or overuse. It can progress to a chronic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)